Amphastar Pharmaceuticals, Inc. Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • Amphastar Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $8.61M, a 2064% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $35.4M, a 1772% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Interest Expense for 2023 was $27.2M, a 1371% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Interest Expense for 2022 was $1.85M, a 109% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Interest Expense for 2021 was $885K, a 137% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $27.2M +$25.3M +1371% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $1.85M +$961K +109% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $885K +$511K +137% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $374K +$255K +214% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $119K -$124K -51% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $243K -$583K -70.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $826K -$198K -19.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $1.02M +$37K +3.75% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $987K +$378K +62.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $609K -$349K -36.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $958K +$174K +22.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $784K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.